Ufp Technologies (UFPT) Revenue Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.98% |
| Dec 31, 2025 | 26.96% |
| Sep 30, 2025 | 28.98% |
| Jun 30, 2025 | 28.80% |
| Mar 31, 2025 | 25.14% |
| Dec 31, 2024 | 23.44% |
| Sep 30, 2024 | 24.06% |
| Jun 30, 2024 | 16.47% |
| Mar 31, 2024 | 17.28% |
| Dec 31, 2023 | 14.89% |
| Sep 30, 2023 | 16.09% |
| Jun 30, 2023 | 15.33% |
| Mar 31, 2023 | 17.89% |
| Dec 31, 2022 | 19.64% |
| Sep 30, 2022 | 22.13% |
| Jun 30, 2022 | 20.02% |
| Mar 31, 2022 | 13.97% |
| Dec 31, 2021 | 9.07% |
| Sep 30, 2021 | 6.39% |
| Jun 30, 2021 | 5.97% |
| Mar 31, 2021 | 7.09% |
| Dec 31, 2020 | 5.88% |
| Sep 30, 2020 | 4.68% |
| Jun 30, 2020 | 3.16% |
| Mar 31, 2020 | 7.28% |
| Dec 31, 2019 | 7.34% |
| Sep 30, 2019 | 6.89% |
| Jun 30, 2019 | 8.60% |
| Mar 31, 2019 | 6.46% |
| Dec 31, 2018 | 7.70% |
| Sep 30, 2018 | 6.62% |
| Jun 30, 2018 | 6.47% |
| Mar 31, 2018 | 4.96% |
| Dec 31, 2017 | 2.21% |
| Sep 30, 2017 | 2.22% |
| Jun 30, 2017 | 2.39% |
| Mar 31, 2017 | 3.01% |
| Dec 31, 2016 | 3.01% |
| Sep 30, 2016 | 3.88% |
| Jun 30, 2016 | 2.50% |
| Mar 31, 2016 | 1.84% |
| Dec 31, 2015 | 1.41% |
| Sep 30, 2015 | 2.48% |
| Jun 30, 2015 | 4.03% |